Patents by Inventor Christine Desmedt

Christine Desmedt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EPIGENETIC PORTRAITS OF HUMAN BREAST CANCERS
    Publication number: 20130296328
    Abstract: The present invention provides new target gene regions for use in prediction, prognosis, diagnosis and therapy of breast cancer, based on the differential methylation profile of said targets in samples from subjects with breast cancer and healthy subjects.
    Type: Application
    Filed: January 20, 2012
    Publication date: November 7, 2013
    Applicant: Université Libre de Bruxelles
    Inventors: François Fuks, Sarah Dedeurwaerder, Christos Sotiriou, Christine Desmedt
  • METHODS AND TOOLS FOR PREDICTING THE EFFICIENCY OF ANTHRACYCLINES IN CANCER
    Publication number: 20120065084
    Abstract: A gene set, kit and method predict the efficiency of anthracyclines-based treatment of breast cancer.
    Type: Application
    Filed: April 16, 2010
    Publication date: March 15, 2012
    Applicant: UNIVERSITE LIBRE DE BRUXELLES
    Inventors: Christos Sotiriou, Christine Desmedt
  • METHOD AND TOOLS FOR PROGNOSIS OF CANCER IN HER2+PARTIENTS
    Publication number: 20110306507
    Abstract: A gene or protein set includes at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, and possibly 40, 45, 50, 55, 60, 65 genes or proteins, antibodies or hypervariable portion thereof directed against the proteins encoded by these genes.
    Type: Application
    Filed: September 5, 2008
    Publication date: December 15, 2011
    Applicant: Universite Libre de Bruxelles
    Inventors: Christos Sotiriou, Benjamin Haibe-Kains, Christine Desmedt
  • METHOD AND TOOLS FOR PROGNOSIS OF CANCER IN ER-PATIENTS
    Publication number: 20100298160
    Abstract: A gene or protein set includes at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 possibly 100, 105, 110 genes or proteins or the entire set or antibodies (or hypervariable portion thereof) directed against the proteins encoded by these genes.
    Type: Application
    Filed: September 5, 2008
    Publication date: November 25, 2010
    Applicant: Universite Libre de Bruxelles
    Inventors: Christos Sotiriou, Benjamin Haibe-Kains, Christine Desmedt